Cargando…
Profile of plecanatide in the treatment of chronic idiopathic constipation: design, development, and place in therapy
Constipation is a multifactorial disorder that can cause significant psychological distress to patients and economic burden on the health care system. Many patients are not satisfied with their current established treatment, highlighting the need for new and improved therapeutic options. Guanylate c...
Autores principales: | Sharma, Amol, Herekar, Anam Asif, Bhagatwala, Jigar, Rao, Satish SC |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348976/ https://www.ncbi.nlm.nih.gov/pubmed/30774407 http://dx.doi.org/10.2147/CEG.S145668 |
Ejemplares similares
-
Plecanatide: a new guanylate cyclase agonist for the treatment of chronic idiopathic constipation
por: Rao, Satish S.C.
Publicado: (2018) -
Influence of Demographic Factors on Clinical Outcomes in Adults With Chronic Idiopathic Constipation Treated With Plecanatide
por: Rao, Satish S.C., et al.
Publicado: (2023) -
Clinical utility of plecanatide in the treatment of chronic idiopathic constipation
por: Islam, Bianca N, et al.
Publicado: (2018) -
Randomized clinical trial: efficacy and safety of plecanatide in the treatment of chronic idiopathic constipation
por: DeMicco, Michael, et al.
Publicado: (2017) -
A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation
por: Miner Jr, Philip B, et al.
Publicado: (2017)